TAMPA, Fla., Feb. 24, 2026 /PRNewswire/ — TuHURA Biosciences, Inc. (NASDAQ:HURA) (“TuHURA” or the “Company”), a Phase 3 immuno-oncology company…
Read More
BURLINGTON, Mass., Feb. 24, 2026 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Raymond…
Read More
NASHVILLE, Tenn., Feb. 24, 2026 /PRNewswire/ — Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it…
Read More
ANDOVER, Mass., Feb. 24, 2026 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming…
Read More